Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Controversies in Hepatocellular Carcinoma / / edited by Nancy S. Reau, Amit G. Singal
| Controversies in Hepatocellular Carcinoma / / edited by Nancy S. Reau, Amit G. Singal |
| Autore | Reau Nancy S |
| Edizione | [1st ed. 2025.] |
| Pubbl/distr/stampa | Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2025 |
| Descrizione fisica | 1 online resource (548 pages) |
| Disciplina | 616.994 |
| Altri autori (Persone) | SingalAmit G |
| Soggetto topico |
Oncology
Liver Physiology Drug delivery systems Hepatic Physiology Drug Delivery |
| ISBN | 3-031-90225-4 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Section 1 - Risk Assessment and Chemoprevention -- Controversy 1 - Should All Patients with Hepatitis B Virus Undergo Hepatocellular Carcinoma Surveillance? -- Controversy 2 - Should Hepatocellular Carcinoma Surveillance Be Restricted to Those with Cirrhosis Among Patients With Hepatitis C? -- Controversy 3 - Should Hepatocellular Carcinoma Surveillance Be Performed in Patients with Noncirrhotic Nonalcoholic Steatohepatitis? -- Controversy 4 -Can Risk Stratification Models Be Used to Identify Patients without Cirrhosis who Might Benefit From Hepatocellular Carcinoma Surveillance? -- Controversy 5 - Should Hepatocellular Carcinoma Surveillance Be Performed Only for Patients with Decompensated Cirrhosis if They Are Listed for Liver Transplantation? -- Controversy 6 - Should Statins and Aspirin Be Used for Hepatocellular Carcinoma Chemoprevention in Patients with Cirrhosis? -- Section 2 - Liver Cancer Surveillance -- Controversy 7 - Should A Randomized Controlled Trial of Hepatocellular Carcinoma in Patients with Cirrhosis Be Performed? -- Controversy 8 - Should Contrast-Enhanced Computed Tomography and/or Magnetic Resonance Imaging Play a Routine Role in Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis? -- Controversy 9 - Should Biomarkers, Such as Alpha Fetoprotein, Play a Routine Role in Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis? -- Controversy 10 - Should Patients with Hepatitis C Virus Cirrhosis Undergo Hepatocellular Carcinoma Surveillance Indefinitely? -- Controversy 11 - Should Patients with Hepatitis C Virus Cirrhosis Undergo Hepatocellular Carcinoma Surveillance Indefinitely? -- Section 3 - Diagnosis -- Controversy 12 - Should All Liver Lesions in Patients with Cirrhosis Be Characterized and Reported Using Liver Imaging Reporting and Data System Criteria? -- Controversy 13 - Can Imaging Findings of Arterial Enhancement and Washout Still Represent a Benign Liver Lesion? -- Controversy 14 - Should Diagnostic Liver Biopsy Be Performed in Patients with Cirrhosis who Have Characteristic Imaging Features of Hepatocellular Carcinoma? -- Controversy 15 - Is Contrast-Enhanced Ultrasound Sufficiently Accurate to Be Used for Noninvasive Diagnosis of Hepatocellular Carcinoma? -- Section 4 - Prognosis -- Controversy 16 - Should Barcelona Clinic Liver Cancer Staging Be Used as the Preferred Staging System for Hepatocellular Carcinoma? -- Section 5 - TreatmentControversy 17 - Should Resection Be the Preferred Therapeutic Option for Patients Within the Milan Criteria and Compensated Cirrhosis Without Portal Hypertension? -- Controversy 18 - Should Liver Transplantation Be the Preferred Therapeutic Option in Patients with Compensated Cirrhosis and Portal Hypertension? -- Controversy 19 - Should Radiation-Based Therapy Be Considered in All Patients with Hepatocellular Carcinoma? -- Controversy 20 - Should Transarterial Radioembolization be the First-Line Therapy Compared to Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma? -- Controversy 21 - Should All Patients Listed for Liver Transplantation Receive Bridging Therapy Before Transplant? -- Controversy 22 - Should Transplant Criteria Be Broadened Beyond United Network for Organ Sharing (UNOS) Downstaging Protocol to Include Larger Tumors? -- Controversy 23 - Should All Tyrosine Kinase Inhibitors Be Considered Equal for First-Line Hepatocellular Carcinoma Treatment? -- Controversy 24 - Should All Patients Be Considered for Locoregional Therapy Before Systemic Therapy? -- Controversy 25 - Should Direct-Acting Antivirals Be Given to Patients with Hepatocellular Carcinoma? -- Controversy 26 - Should Locoregional Therapy Be Given in Combination with Systemic Therapy? -- Controversy 27 - Should Patients with Decompensated Cirrhosis Receive Systemic Therapy? -- Controversy 28 - Would Effectively Downstaging Hepatocellular Carcinoma Allow All Patients to Be Considered for Liver Transplantation? -- Controversy 29 - Should Surgery Be Considered for Hepatocellular Carcinoma if Unable to Be Performed at Presentation? -- Controversy 30- Should Rapamune (Sirolimus)-Based Immunomodulation Be Given Post Transplant for Those Transplanted for or Found to Have Incidental Hepatocellular -- Controversy 31- Should Systemic Therapy Be Offered to all Patients Post Transplant for Those Transplanted for or Found to Have Incidental Hepatocellular Carcinoma? -- Controversy 32 - Should Post-Liver Transplantation Surveillance for Hepatocellular Carcinoma (HCC) Stop if There Is no HCC Recurrence After 5 Years?. |
| Record Nr. | UNINA-9911015964003321 |
Reau Nancy S
|
||
| Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2025 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Textbook of Robotic Liver Surgery / / edited by Mathieu D'Hondt, Iswanto Sucandy
| Textbook of Robotic Liver Surgery / / edited by Mathieu D'Hondt, Iswanto Sucandy |
| Autore | D'Hondt Mathieu |
| Edizione | [1st ed. 2024.] |
| Pubbl/distr/stampa | Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2024 |
| Descrizione fisica | 1 online resource (464 pages) |
| Disciplina | 617 |
| Altri autori (Persone) | SucandyIswanto |
| Soggetto topico |
Surgery
Gastroenterology Liver Physiology Internal medicine Hepatic Physiology Internal Medicine |
| ISBN |
9783031765360
3031765362 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction -- Robotic Systems, Patient Preparation and Anesthesia in robotic liver surgery -- Different approaches in robotic liver surgery -- Learning curves and training in robotic liver surgey -- Robotic liver surgery for malignant tumors -- Robotic liver surgery: Procedures and Technical aspects -- New technology, financial impact, registries and the future of robotic liver surgery. |
| Record Nr. | UNINA-9910947534903321 |
|
D'Hondt Mathieu
|
||
| Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto topico
-
Hepatic Physiology
(2)
- Liver (2)
- Physiology (2)
- Drug Delivery (1)
- Drug delivery systems (1)